期刊文献+

银屑病发病机制研究进展 被引量:51

Research Progress Etiology and Pathogenesis of Psoriasis
下载PDF
导出
摘要 银屑病是一种以表皮增厚、免疫反应和血管增生为特点的疾病。其发病与固有免疫系统和获得性免疫系统相关。其免疫反应发生的中心环节涉及NF-κB,IFN-γ和IL-23信号通路及抗原呈递等多个方面。目前临床上已有如TNF-α、IL-23、IL-17生物靶向治疗取得了很好的疗效,强调了这些炎症介质在临床中的重要性。近几年有研究发现IL-1β/NF-κB通道的激活、IL-23参与胰岛细胞的免疫反应,均可以导致胰岛素抵抗,说明胰岛素抵抗作用可能与了银屑病发病有关。文章就近几年银屑病的发病机制及银屑病相关并发症的研究进展综述如下。 Psoriasis is eharaeterized by the parallel appearanee of epidermal hyperproliferation, inflammation and angioqeo- genesis. It is driven by an intimate interplay between the innate and the adaptive immunesystems. The eentral axes of psoriatic in- flammation enmprises the tmelear factor -kB,inlerferon -g and interleukin (IL) -23 signaling pathways as well as antigen pres- enlation. Biologie therapies targeting tumor neerosis factor- α,lL- 23 or IL- 17 are highly effeetive, underlining the clinical im- portance of these inflammatory mediators. In recent years, Ihere are some sludies have found that the chaunel of IL- 1β/NF - κB aetived and IL - 23 in islet cells of the immune respmse, they can lead to insulin resistance, h suggests thai insulin resistance may be involved in the pathogenesis of psoriasis. In this paper,the etiology and pathogenesis of psoriasis in recent years and the researeh progress of complications associated with psoriasis were reviewed as fi)llows.
出处 《辽宁中医杂志》 CAS 北大核心 2017年第6期1334-1338,共5页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然基金青年科学基金(81403410) 北京市科技计划课题"十病十药"研发(Z141100002214015)
关键词 银屑病 免疫反应 IL-23 IL-17 胰岛素抵抗 发病机制 研究进展 psoriasis immunoreaelion IL - 23 IL - 17 insulin resistance pathogenesis research progress
  • 相关文献

参考文献1

二级参考文献20

  • 1Kaur S, Zilmer K, Leping V, et al. Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis [J]. Dermatology, 2012, 225(1):54-61.
  • 2Kiran Z, Zuberi BF, Anis D, et al. Insulin resistance in nondiabetic patients of chronic Hepatitis C [J] . Pak J Med Sci, 2013, 29(1):201-204.
  • 3Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006[J] . Arch Dermatol, 2011, 147(4):419-424.
  • 4Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis [J]. Indian J Dermatol Venereol Leprol, 2010, 76(6):662-665.
  • 5Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis [J]. Metab Syndr Relat Disord, 2010, 8(4):331-334.
  • 6MasajtisZagajewska A,Majer J,Nowicki M. Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulinresistanthypertensive patientsa randomized, crossover trial [J]. Hypertens Res,2010, 33(4):348-353.
  • 7Spravchikov N, Sizyakov G, Gartsbein M, et al. Glucose effects on skin keratinocytes implications for diabetes skin complications [J]. Diabetes, 2001, 50(7):1627-1635.
  • 8Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance [J]. Br J Dermatol, 2007, 157(6):1249-1251.
  • 9Gilhar A, Yaniv R, Assy B, et al. Fas pulls the trigger on psoriasis [J]. Am J Pathol, 2006, 168(1):170-175.
  • 10AlKarkhi IH, Ibrahim AE, Yaseen AK. Levels of insulin, IL-6 and CRP in patients with unstable angina [J]. Adv Clin Exp Med, 2013, 22(5):655-658.

共引文献9

同被引文献645

引证文献51

二级引证文献304

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部